Literature DB >> 34306707

Idiopathic pulmonary vein thrombosis treated with apixaban.

Dallis Ngo1, Ghulam Aftab1, Arjun Madhavan1, Amar Bukhari1.   

Abstract

Pulmonary vein thrombosis (PVT) is a rare clinical finding that is potentially fatal and with an unknown incidence rate as known cases exist predominantly in case reports. We present the case of a 58-year-old female who reported sudden onset of chest pain, shortness of breath, and dyspnoea on exertion. A computed tomography (CT) pulmonary angiogram was negative for evidence of pulmonary embolism; however, it did demonstrate the evidence of thrombosis of the right lower lobe segmental pulmonary vein. She had no identifiable aetiologies for her PVT; therefore, she was diagnosed with idiopathic PVT and was treated successfully with apixaban. This case represents the 14th incidence of idiopathic PVT in the current body of medical literature and the first case of successful treatment with apixaban.
© 2021 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.

Entities:  

Keywords:  Apixaban; breast cancer; idiopathic; pulmonary vein thrombosis; venous thrombosis

Year:  2021        PMID: 34306707      PMCID: PMC8292945          DOI: 10.1002/rcr2.803

Source DB:  PubMed          Journal:  Respirol Case Rep        ISSN: 2051-3380


Introduction

Pulmonary vein thrombosis (PVT) is a rare and life‐threatening condition commonly associated with interventional thoracic procedures such as thoracic surgery and radiofrequency catheter ablation for atrial fibrillation. Idiopathic PVT is exceedingly rare with an unknown incidence rate as it has only been reported in case reports. We present a case of idiopathic PVT which represents the 14th identified case within the current body of medical literature and the first ever case successfully treated with apixaban.

Case Report

We present a 53‐year‐old female with a past medical history significant for right breast cancer, status‐post lumpectomy followed by completion of six rounds of chemotherapy (Taxotere [Sanofi‐Aventis, France], Herceptin [Genentech, USA], and carboplatin) and 36 rounds of radiation six years prior and currently in remission, hypertension, and bilateral lower extremity varicose veins, status‐post phlebectomy 14 years prior complicated by a post‐operative right lower extremity deep vein thrombosis treated successfully with three months of Coumadin (Bristol Myers Squibb, USA). She presented to the hospital with complaints of sudden onset sharp, constant, and non‐radiating substernal chest pain while eating dinner with her husband at home. Her symptoms were not associated with nausea, diaphoresis, haemoptysis, palpitations, or syncope. She denied any symptoms suggestive of acid reflux; however, she did endorse shortness of breath and dyspnoea on exertion. There were no provoking factors. She denied any recent history of recent immobilization, trauma, calf/leg pain or swelling, long car rides, or air travel. There was no surgical history of prior lobectomies, lung transplants, or atrial fibrillation ablations. Her family history is negative for blood dyscrasias or blood clots and her social history is negative for tobacco or illicit drug use. She has no active cancer disease. Her initial investigations in the emergency department demonstrated completely unremarkable parameters in regards to her complete blood count, complete metabolic panel, prothrombin time, troponin‐I, d‐dimer, and electrocardiogram. Her physical examination was unrevealing. The chest radiograph did not demonstrate evidence of acute disease. A computed tomography (CT) pulmonary angiogram was performed which did not demonstrate evidence of pulmonary arterial embolism; however, there was evidence of significant thrombosis of a right lower lobe segmental pulmonary vein without an obvious visualizable aetiology (Fig. 1). Her transthoracic echocardiogram demonstrated normal left ventricular systolic function without evidence of right heart strain or elevated right ventricular systolic pressure. There was no evidence of mitral stenosis and no presence intra‐atrial or ventricular thrombus formation. A hypercoagulable workup, consisting of anti‐cardiolipin IgG/M, lupus anticoagulant, and proteins C and S, was performed and found to be negative. No identifiable source was determined to be the underlying culprit; therefore, her pulmonary vein thrombus was determined to be idiopathic in nature.
Figure 1

Axial view of a computed tomography (CT) pulmonary angiogram demonstrating a pulmonary vein thrombus (red arrow) involving the right lower lobe segmental vein.

Axial view of a computed tomography (CT) pulmonary angiogram demonstrating a pulmonary vein thrombus (red arrow) involving the right lower lobe segmental vein. The rest of her hospital course was unremarkable after the initiation of intravenous therapeutic anticoagulation via unfractionated heparin. She was discharged home with instructions to continue apixaban for three months followed by re‐evaluation in the outpatient setting. During her follow‐up visit in our outpatient pulmonary clinic, she was found to be in good health with complete resolution of all prior presenting symptoms and normoxic on ambient air. A follow‐up CT scan was offered to evaluate for resolution of the thrombus; however, due to the risk of further radiation, the patient declined.

Discussion

PVT is a rare clinical condition with an unknown incidence rate as majority of our current understanding stems from case reports. Due to the non‐specific nature of its presentation, it presents a diagnostic challenge. Patients may demonstrate evidence of dyspnoea, pleuritic chest pain, cough, or haemoptysis which may lead to the misdiagnosis of a pulmonary embolism. Clinically, there is no difference in patient presentation of PVT in a provoked scenario and idiopathic [1]. The rare occurrence of identified cases in the current literature could be explained by the extensive collateral venous network within the pulmonary circulation, although, if left untreated, it could potentially result in interstitial pulmonary oedema, right ventricular failure, and pulmonary infarction [1, 2]. Dyspnoea from PVT is not always conducive to an abnormal resting echocardiogram as demonstrated by prior reported cases in Table 1. Such a large pulmonary vein thrombus can cause a reduction in total pulmonary vascular volume with associated decrements of left atrial volume and cardiac output to meet exercise demands [15, 16]. This may be more evident with a more invasive exercise right heart catheterization.
Table 1

Idiopathic PVT cases reported in the current literature.

AuthorAge and genderComorbiditiesClinical presentationMethod of diagnosis and resultAdditional workupTreatment
Selvidge and Gavant, 1999 [3]33 FSickle cell trait, tobacco smoker, cocaineAcute onset left‐sided abdominal pain, nausea, and vomitingCT abdomen with contrast: irregular, small areas of non‐enhancing infarction within the spleen and a 2‐cm diameter filling the defect in the left atrium extending from a thrombus in the distal right lower pulmonary vein

CXR: patchy opacity in the right lower lobe

TTE: normal findings

ECG‐gated MRI: bland thrombosis of the right lower pulmonary vein with extension into the left atrium

Oral anticoagulant
Alexander et al., 2009 [2]47 FNoneMassive haemoptysis, left chest pain, dyspnoeaPathology of the left lower lobectomy: sections of the lung parenchyma demonstrated red hepatization with thrombosis of the pulmonary venous systemTTE: no evidence of thrombosis in the left atriumSurgical resection of the affected lobe and thrombectomy
Komatsu et al., 2011 [4]57 MHyperlipidaemiaChest pain with myocardial infarctionCT chest: bilateral lower pulmonary vein thrombusWarfarin. Antiplatelet for CAD
Mumoli and Cei, 2012 [5]80 MCoronary artery disease s/p CABG, congestive heart failureAcute shortness of breathCT chest: bilateral pleural effusions and a large thrombus in the left superior pulmonary vein

CXR: near‐round opacity in the upper left lobe with fissure involvement

TTE: ejection fraction 30%

Hypercoagulable workup: normal except homocysteine of 18.5 μmol/L

Enoxaparin bridged to warfarin
Takeuchi, 2012 [6]79 MHypertensionChest pain64‐MDCT: 17.2 × 1.2 × 1.3 mm thrombus was situated at the proximal side of the left upper pulmonary vein and calcification of the left anterior descending arteryWarfarin
Wu et al., 2012 [7]30 MHypertensionChest painCT chest PE protocol: multifocal consolidation and ground‐glass opacities in the left lower lobe, left‐sided effusion, well‐defined filling defect, and occlusion within a left inferior pulmonary vein and homogenous hypodense attenuation in the left atrium after contrast administration

d‐dimer: normal

Thrombophilia workup (antithrombin III, protein C/S): negative

Tumour markers (CEA, AFP, CA19‐9, CA‐125, NSE): negative

TEE: 2 cm diameter filling defects in the left atrium suggestive of thrombus

Unknown
Takeuchi, 2013 [8]73 MHyperlipidaemia, asthmaChest pain64‐MDCT: no coronary artery stenosis. Thrombus in the left upper pulmonary vein

CXR: normal

d‐dimer: <0.5 μg/mL

Protein S activity: 96%

Protein C activity: 131%

Dabigatran 150 mg q12 h
Takeuchi, 2013 [9]70 MCoronary artery diseaseChest pain64‐MDCT: large thrombi in the left lower pulmonary vein expanding into the left atrium

CXR: normal

TTE: thrombus in the left atrium 30.2 mm × 8.1 mm, no thrombus in left atrial appendage

Aspirin 100 mg
Takeuchi, 2014 [10]68, MHypertension, hyperlipidaemia, strokeChest pain64‐MDCT: calcification of the coronary arteries. A thrombus in the right lower pulmonary vein

CXR: normal

d‐dimer: 0.5 μg/mL

Protein S activity: 66%

Protein C activity: 155%

Dabigatran
Takeuchi, 2015 [11]82 MHypertension, hyperlipidaemiaChest pain64‐MDCT: thrombus in the right lower pulmonary vein

d‐dimer: 0.5 μg/mL

Protein S activity: 85%

Protein C activity: 107%

Dabigatran
Rana et al., 2016 [12]63 MNoneChest painCTPA: no pulmonary embolism. Thrombus in the pulmonary vein extending into the left atrium

CXR: normal

d‐dimer: 1800 ng/mL

TTE: normal

TEE: confirmed PVT. Pulmonary artery systolic pressure 28 mmHg

Thrombophilia workup: normal

Tumour markers (AFP, beta‐2 microglobulin, CA 19‐9, PSA): normal

Low‐molecular weight heparin bridged to warfarin
Patel et al., 2017 [13]77 FCarcinoid tumour s/p resection, hypertension, hyperlipidaemiaAcute shortness of breathCTA chest: no pulmonary embolism. Non‐exclusive thrombus in the inferior

TTE: positive McConnell's sign

Thrombophilia workup (factor V Leiden, protein C/S): normal

Lower extremity duplex US: normal

Rivaroxaban
Barreiro et al., 2018 [14]26 FGravida 5 para 5Chest painCTA chest: right hilar mass or lymph node causing encasement of the right main pulmonary artery and infiltrates in the right middle and lower lobes, consistent with PVT

CXR: bilateral infiltrations in lower lobes in an interstitial pattern

ANA, lupus anticoagulant, and C‐ANCA: negative

P‐ANCA: elevated

Oral anticoagulant
Ngo, 2021 (current case)53 FRight breast cancer in remission, varicose veinsChest pain, shortness of breathCTPA: significant thrombosis of the right lower lobe segmental pulmonary vein

CXR: normal

d‐dimer: normal

Anti‐cardiolipin, lupus anticoagulant, protein C/S: normal

Apixaban

AFP, alpha‐fetoprotein; ANA, antinuclear antibody; C‐ANCA, antineutrophil cytoplasmic antibodies; CABG, coronary artery bypass graft; CAD, coronary artery disease; CEA, carcinoembryonic antigen; CT, computed tomography; CTA, computed tomography angiography; CTPA, computed tomography pulmonary angiogram; CXR, chest X‐ray; ECG, electrocardiogram; MDCT, multidetector computed tomography; MRI, magnetic resonance imaging; NSE, neuron‐specific enolase; P‐ANCA, perinuclear anti‐neutrophil cytoplasmic antibodies; PE, pulmonary embolism; PSA, prostate‐specific antigen; PVT, pulmonary vein thrombosis; s/p, status post; TTE, transthoracic echo; US, ultrasound.

Idiopathic PVT cases reported in the current literature. CXR: patchy opacity in the right lower lobe TTE: normal findings ECG‐gated MRI: bland thrombosis of the right lower pulmonary vein with extension into the left atrium CXR: near‐round opacity in the upper left lobe with fissure involvement TTE: ejection fraction 30% Hypercoagulable workup: normal except homocysteine of 18.5 μmol/L d‐dimer: normal Thrombophilia workup (antithrombin III, protein C/S): negative Tumour markers (CEA, AFP, CA19‐9, CA‐125, NSE): negative TEE: 2 cm diameter filling defects in the left atrium suggestive of thrombus CXR: normal d‐dimer: <0.5 μg/mL Protein S activity: 96% Protein C activity: 131% CXR: normal TTE: thrombus in the left atrium 30.2 mm × 8.1 mm, no thrombus in left atrial appendage CXR: normal d‐dimer: 0.5 μg/mL Protein S activity: 66% Protein C activity: 155% d‐dimer: 0.5 μg/mL Protein S activity: 85% Protein C activity: 107% CXR: normal d‐dimer: 1800 ng/mL TTE: normal TEE: confirmed PVT. Pulmonary artery systolic pressure 28 mmHg Thrombophilia workup: normal Tumour markers (AFP, beta‐2 microglobulin, CA 19‐9, PSA): normal TTE: positive McConnell's sign Thrombophilia workup (factor V Leiden, protein C/S): normal Lower extremity duplex US: normal CXR: bilateral infiltrations in lower lobes in an interstitial pattern ANA, lupus anticoagulant, and C‐ANCA: negative P‐ANCA: elevated CXR: normal d‐dimer: normal Anti‐cardiolipin, lupus anticoagulant, protein C/S: normal AFP, alpha‐fetoprotein; ANA, antinuclear antibody; C‐ANCA, antineutrophil cytoplasmic antibodies; CABG, coronary artery bypass graft; CAD, coronary artery disease; CEA, carcinoembryonic antigen; CT, computed tomography; CTA, computed tomography angiography; CTPA, computed tomography pulmonary angiogram; CXR, chest X‐ray; ECG, electrocardiogram; MDCT, multidetector computed tomography; MRI, magnetic resonance imaging; NSE, neuron‐specific enolase; P‐ANCA, perinuclear anti‐neutrophil cytoplasmic antibodies; PE, pulmonary embolism; PSA, prostate‐specific antigen; PVT, pulmonary vein thrombosis; s/p, status post; TTE, transthoracic echo; US, ultrasound. Identified causes of PVT are usually associated with manipulation of the pulmonary veins during lung transplantation or lobectomy, radiofrequency ablation for atrial fibrillation, sclerosing mediastinitis, pulmonary malignancy, atrial myxoma, congenital pulmonary vein narrowing, or mitral stenosis [17]. In a review of five cases of idiopathic PVT, four cases were found to have normal d‐dimer levels in addition to 17 of 23 cases of PVT with an identifiable cause, suggesting that d‐dimer does not appear to be correlated with the presence of a PVT [13]. There is no gold standard for the diagnosis of PVT. Diagnosis is often made with the use of a combination of multiple imaging modalities such as transoesophageal echocardiogram, cardiac gated magnetic resonance imaging, pulmonary angiogram, or CT pulmonary angiogram [14]. CT scans that are typically meant to evaluate the pulmonary arterial anatomy may be misleading due to the poor opacification and mixing artefact in the pulmonary vein, potentially mimicking thrombus and left atrial masses. Utilizing longer scan delays allows for better evaluation of both pulmonary veins and left atrium [1]. Although our patient did not receive a repeat CT scan to demonstrate resolution, citing risk of radiation, it is not standard of practice to do so if the patient's symptoms have resolved as clot resolution occurs in as little as three weeks with anticoagulant treatment [18]. To date, there have been no randomized control trials evaluating treatments for PVT; however, multiple case reports have demonstrated success with the use of warfarin, rivaroxaban, and dabigatran [13, 14]. Our case is rare in that it represents the 14th case (Table 1) of a reported idiopathic PVT and the first reported treated successfully with apixaban.

Disclosure Statement

Appropriate written informed consent was obtained for publication of this case report and accompanying images.

Author Contribution Statement

All authors listed were directly and equally involved in the conceptualization, literature review, and writing of this manuscript.
  17 in total

Review 1.  Idiopathic pulmonary vein thrombosis: detection by CT and MR imaging.

Authors:  S D Selvidge; M L Gavant
Journal:  AJR Am J Roentgenol       Date:  1999-06       Impact factor: 3.959

2.  Idiopathic pulmonary vein thrombosis complicated with old myocardial infarction detected by multidetector row computed tomography.

Authors:  Sei Komatsu; Teruaki Kamata; Astuko Imai; Kazuaki Miyaji; Tomoki Ohara; Mitsuhiko Takewa; Yoshinobu Shimizu; Jyunichi Yoshida; Atsushi Hirayama; Shinsuke Nanto; Kazuhisa Kodama
Journal:  J Cardiol Cases       Date:  2011-02-20

3.  Dyspnea after Pulmonary Embolism.

Authors:  David Christiansen; Timothy Baillie; Susanna Mak; John Granton
Journal:  Ann Am Thorac Soc       Date:  2019-07

4.  64-MDCT can depict the thrombi expanded from the left lower pulmonary vein to the left atrium in the patient with angina pectoris.

Authors:  Hidekazu Takeuchi
Journal:  BMJ Case Rep       Date:  2013-04-03

5.  Chest pain caused by pulmonary vein thrombi could be curable by dabigatran.

Authors:  Hidekazu Takeuchi
Journal:  BMJ Case Rep       Date:  2014-03-13

6.  64-MDCT showed the thrombus in the pulmonary vein of the patient with angina pectoris.

Authors:  Hidekazu Takeuchi
Journal:  BMJ Case Rep       Date:  2012-10-13

7.  Idiopathic Pulmonary Vein Thrombus Extending into Left Atrium: A Case Report and Review of the Literature.

Authors:  Muhammad Asim Rana; Nicholas Tilbury; Yashwant Kumar; Habib Ahmad; Kamal Naser; Ahmed F Mady; Awani Patel
Journal:  Case Rep Med       Date:  2016-05-05

8.  A pulmonary vein thrombus in a patient with autonomic nervous dysfunction.

Authors:  Hidekazu Takeuchi
Journal:  Int J Cardiol Heart Vasc       Date:  2015-05-08

Review 9.  Pulmonary Vein Thrombosis: A Recent Systematic Review.

Authors:  Gerard Chaaya; Priya Vishnubhotla
Journal:  Cureus       Date:  2017-01-23

10.  Idiopathic pulmonary fibrosis associated with pulmonary vein thrombosis: a case report.

Authors:  Raquel A Cavaco; Sunny Kaul; Timothy Chapman; Romina Casaretti; Barbara Philips; Andrew Rhodes; Michael R Grounds
Journal:  Cases J       Date:  2009-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.